Company: CHY
Filing Date: 2025-02-24
Form Type: 424B5
Source: 0001104659-25-016491
Chunk: 0

Company: CALAMOS CONVERTIBLE & HIGH INCOME FUND
Filing Date: 2025-02-24
Form: 424B5
Chunk 0
---
Filed pursuant to Rule 424(b)(5) File No. 333-285119 Prospectus Supplement
(To Prospectus dated February 21, 2025) Calamos Convertible and High Income Fund Up to 17,140,125 Common Shares Calamos Convertible and High Income Fund (the “Fund,” “we,” “us,” or “our”) has entered into a distribution agreement dated February 24, 2025 (the "Distribution Agreement") with Foreside Fund Services, LLC (the "Distributor"), relating to the Fund's common shares of beneficial interest ("common shares") offered by this prospectus supplement and the accompanying prospectus. The Distributor has entered into a sub-placement agent agreement dated February 24, 2025 (the "Sub-Placement Agent Agreement") with UBS Securities LLC (the "Sub-Placement Agent"), relating to the Fund's common shares offered by this prospectus supplement and the accompanying prospectus. In accordance with the terms of the Sub-Placement Agent Agreement, we may offer and sell up to 17,140,125 of our common shares, no par value per share, from time to time through the Sub-Placement Agent, as the sub-placement agent for the offer and sale of the common shares. Under the Investment Company Act of 1940, as amended (the "1940 Act"), the Fund may not sell any common shares at a price below the current net asset value of such common shares, exclusive of any distributing commission or discount. The Fund is a diversified, closed-end management investment company that commenced investment operations in May 2003. Our investment objective is to provide total return through a combination of capital appreciation and current income. Our common shares are listed on the Nasdaq Global Select Market (“Nasdaq”) under the symbol “CHY.” As of January 31, 2025, the last reported sale price for our common shares was $11.42 per share. As of January 31, 2025, the last reported net asset value for our common shares was $10.84 per share. Sales of our common shares, if any, under this prospectus supplement and the accompanying prospectus may be made in negotiated transactions or transactions that are deemed to be “at the market” as defined in Rule 415 under the Securities Act of 1933, as amended (the “1933 Act”), including sales made directly on the Nasdaq or sales made to or through a market maker other than on an exchange. The Distrib